There have been 50 recent insider transactions recorded for Mereo BioPharma Group plc (MREO), including 26 buys and 24 sells. Total insider buying was valued at $5.75M and total insider selling at $2.67M.
Notable insiders with recent activity include Wyzga Michael S, Pakianathan Deepika, Yoskowitz Marc J. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — MREO
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-02-26 |
Wyzga Michael S |
Director |
RSU Award |
66,000 |
$0.39 |
$25.74K |
66,000 |
| 2026-02-26 |
Pakianathan Deepika |
Director |
RSU Award |
66,000 |
$0.39 |
$25.74K |
66,000 |
| 2026-02-26 |
Yoskowitz Marc J |
Director |
RSU Award |
66,000 |
$0.39 |
$25.74K |
66,000 |
| 2026-02-26 |
Jenkins Annalisa |
Director |
RSU Award |
66,000 |
$0.39 |
$25.74K |
66,000 |
| 2026-02-26 |
Jacquet Pierre |
Director |
RSU Award |
66,000 |
$0.39 |
$25.74K |
66,000 |
| 2026-02-26 |
Bender Jeremy |
Director |
RSU Award |
66,000 |
$0.39 |
$25.74K |
66,000 |
| 2026-02-26 |
Shames Daniel |
Director |
RSU Award |
66,000 |
$0.39 |
$25.74K |
66,000 |
| 2026-02-26 |
Ekblom Anders |
Director |
RSU Award |
66,000 |
$0.39 |
$25.74K |
66,000 |
| 2026-02-01 |
Scots-knight Denise |
Chief Executive Officer |
RSU Award |
345,000 |
$1.00 |
$345K |
345,000 |
| 2026-02-01 |
Lewicki John A. |
Chief Scientific Officer |
RSU Award |
46,637 |
$1.00 |
$46.64K |
46,637 |
| 2026-02-01 |
Sermon Charles |
General Counsel |
RSU Award |
105,250 |
$1.00 |
$105.25K |
105,250 |
| 2026-02-01 |
Fox Christine Ann |
Chief Financial Officer |
RSU Award |
105,250 |
$1.00 |
$105.25K |
105,250 |
| 2026-02-01 |
Hughes-wilson Alexandra |
See Remarks |
RSU Award |
61,250 |
$1.00 |
$61.25K |
61,250 |
| 2025-02-05 |
Wyzga Michael S |
Director |
RSU Award |
30,487 |
- |
- |
30,487 |
| 2025-02-05 |
Pakianathan Deepika |
Director |
RSU Award |
55,000 |
$3.16 |
$173.8K |
55,000 |
| 2025-02-05 |
Yoskowitz Marc J |
Director |
RSU Award |
13,719 |
- |
- |
13,719 |
| 2025-02-05 |
Jenkins Annalisa |
Director |
RSU Award |
15,243 |
- |
- |
15,243 |
| 2025-02-05 |
Jacquet Pierre |
Director |
RSU Award |
15,243 |
- |
- |
15,243 |
| 2025-02-05 |
Bender Jeremy |
Director |
RSU Award |
16,768 |
- |
- |
16,768 |
| 2025-02-05 |
Shames Daniel |
Director |
RSU Award |
13,719 |
- |
- |
13,719 |
| 2025-02-05 |
Ekblom Anders |
Director |
RSU Award |
19,054 |
- |
- |
19,054 |
| 2025-01-25 |
Scots-knight Denise |
Chief Executive Officer |
RSU Award |
825,000 |
$2.91 |
$2.4M |
825,000 |
| 2025-01-25 |
Lewicki John A. |
Chief Scientific Officer |
RSU Award |
116,000 |
$2.91 |
$337.56K |
116,000 |
| 2025-01-25 |
Sermon Charles |
General Counsel |
RSU Award |
262,000 |
$2.91 |
$762.42K |
262,000 |
| 2025-01-25 |
Fox Christine Ann |
Chief Financial Officer |
RSU Award |
262,000 |
$2.91 |
$762.42K |
262,000 |
| 2025-01-25 |
Hughes-wilson Alexandra |
See Remarks |
RSU Award |
154,000 |
$2.91 |
$448.14K |
154,000 |
| 2024-09-13 |
Scots-knight Denise |
Chief Executive Officer |
Informative Sell |
60,046 |
$4.22 |
$253.45K |
808,921 |
| 2024-09-13 |
Lewicki John A. |
Chief Scientific Officer |
Informative Sell |
10,937 |
$4.22 |
$46.17K |
78,630 |
| 2024-09-13 |
Sermon Charles |
General Counsel |
Informative Sell |
20,946 |
$4.22 |
$88.41K |
219,061 |
| 2024-09-13 |
Fox Christine Ann |
Chief Financial Officer |
Informative Sell |
19,158 |
$4.22 |
$80.87K |
89,285 |
| 2024-09-13 |
Hughes-wilson Alexandra |
See Remarks |
Informative Sell |
84,008 |
$4.22 |
$354.6K |
50,475 |
| 2024-09-12 |
Scots-knight Denise |
Chief Executive Officer |
Informative Sell |
28,611 |
$4.47 |
$127.97K |
868,967 |
| 2024-09-12 |
Lewicki John A. |
Chief Scientific Officer |
Informative Sell |
5,212 |
$4.47 |
$23.31K |
89,567 |
| 2024-09-12 |
Sermon Charles |
General Counsel |
Informative Sell |
9,980 |
$4.47 |
$44.64K |
240,007 |
| 2024-09-12 |
Fox Christine Ann |
Chief Financial Officer |
Informative Sell |
9,128 |
$4.47 |
$40.83K |
108,443 |
| 2024-09-12 |
Hughes-wilson Alexandra |
See Remarks |
Informative Sell |
40,029 |
$4.47 |
$179.04K |
150,787 |
| 2024-09-11 |
Scots-knight Denise |
Chief Executive Officer |
Option Exercise (Sell) |
188,060 |
- |
- |
- |
| 2024-09-11 |
Lewicki John A. |
Chief Scientific Officer |
Option Exercise (Sell) |
46,000 |
- |
- |
- |
| 2024-09-11 |
Sermon Charles |
General Counsel |
Option Exercise (Sell) |
65,600 |
- |
- |
- |
| 2024-09-11 |
Fox Christine Ann |
Chief Financial Officer |
Option Exercise (Sell) |
60,000 |
- |
- |
- |
| 2024-09-11 |
Hughes-wilson Alexandra |
See Remarks |
Option Exercise (Sell) |
75,000 |
$1.01 |
$75.75K |
- |
| 2024-08-22 |
Pakianathan Deepika |
Director |
Informative Sell |
105,244 |
$4.43 |
$466.21K |
- |
| 2024-06-26 |
Scots-knight Denise |
Chief Executive Officer |
Informative Sell |
92,273 |
$3.39 |
$313.1K |
709,518 |
| 2024-06-26 |
Lewicki John A. |
Chief Scientific Officer |
Informative Sell |
16,808 |
$3.39 |
$57.03K |
48,779 |
| 2024-06-26 |
Sermon Charles |
General Counsel |
Informative Sell |
32,187 |
$3.39 |
$109.22K |
184,387 |
| 2024-06-26 |
Fox Christine Ann |
Chief Financial Officer |
Informative Sell |
29,439 |
$3.39 |
$99.89K |
57,571 |
| 2024-06-26 |
Hughes-wilson Alexandra |
See Remarks |
Informative Sell |
22,968 |
$3.39 |
$77.94K |
34,548 |
| 2024-06-25 |
Scots-knight Denise |
Chief Executive Officer |
Informative Sell |
40,712 |
$3.69 |
$150.39K |
801,791 |
| 2024-06-25 |
Lewicki John A. |
Chief Scientific Officer |
Informative Sell |
7,416 |
$3.69 |
$27.39K |
65,587 |
| 2024-06-25 |
Sermon Charles |
General Counsel |
Informative Sell |
14,202 |
$3.69 |
$52.46K |
216,574 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
